{"nct_id":"NCT02737072","title":"A Study of LY2510924 and Durvalumab in Participants With Solid Tumors","status":"TERMINATED","status_verified_date":"2019-06","start_date":"2016-09","start_date_type":null,"primary_completion_date":"2017-09-25","primary_completion_date_type":"ACTUAL","completion_date":"2017-09-25","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["LLY"]}